Where can I verify the source and access all details for “Novartis Denton Radioligand Therapy Manufacturing Facility”?

This Taiyo project page references Construction Review along with the original URL (https://constructionreviewonline.com/novartis-texas-groundbreaking-marks-fifth-us-radioligand-therapy-site-in-23-billion-expansion/). Taiyo standardizes official data into a consistent, searchable project profile.

Novartis Denton Radioligand Therapy Manufacturing Facility

Q: What is the latest status of the project “Novartis Denton Radioligand Therapy Manufacturing Facility”?

The status recorded for “Novartis Denton Radioligand Therapy Manufacturing Facility” is under construction.

Q: What is the budget and commercial profile for the project “Novartis Denton Radioligand Therapy Manufacturing Facility”?

Taiyo normalizes the budget of “Novartis Denton Radioligand Therapy Manufacturing Facility” to USD 280000000.

Sector: Manufacturing (Industrial) • Location: Denton, Texas, USA

Source: Construction Review

Project

Under Construction

Novartis is constructing a purpose-built 46,000 sq. ft. radioligand therapy manufacturing facility in Denton, Texas, as part of a $23 billion expansion of its US research and manufacturing footprint. The $280 million project will be the fifth US RLT production site and the first in Texas, addressing a supply gap in the southern US for time-sensitive cancer therapies. The facility is expected to be

Status: Under Construction
Sector: Manufacturing (Industrial), Commercial
Location: Denton, Texas, United States of America
Updated: 22 Jul 2026
Source: Construction Review

ConstructChat

Ask ConstructChat about Novartis Denton Radioligand Therapy Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “Novartis Denton Radioligand Therapy Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Denton, Texas, USA. Taiyo aggregates data on it from Construction Review.

Participants

Not available for this record.

Status

Original status	under construction
Taiyo status	Under Construction
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Novartis is constructing a purpose-built 46,000 sq. ft. radioligand therapy manufacturing facility in Denton, Texas, as part of a $23 billion expansion of its US research and manufacturing footprint. The $280 million project will be the fifth US RLT production site and the first in Texas, addressing a supply gap in the southern US for time-sensitive cancer therapies. The facility is expected to be operational in 2028 and will create 150 to 175 skilled jobs.
Original sector	Buildings
Budget

Location

Country	United States of America (USA)
State	Texas
City	Denton

Source

Source	Construction Review
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial), Commercial
Article published date	2026-05-10

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Novartis Denton Radioligand Therapy Manufacturing Facility

Ask ConstructChat about Novartis Denton Radioligand Therapy Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in USA